AH Equity Partners Bio II, L.L.C.
Nautilus Biotechnology, Inc. · 10% Owner
AH Equity Partners Bio II, L.L.C. is listed in public filings as 10 percent owner. This AH Equity Partners Bio II, L.L.C. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Nautilus Biotechnology, Inc. (NAUT). Investors use AH Equity Partners Bio II, L.L.C.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $27M11.7M shares | SellJun 2, 2026 | $10.8M4.6M shares | $2.35 | -- | |
| $2.3M971.9k shares | SellJun 2, 2026 | $902.5K384k shares | $2.35 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| Historical actions before the latest disclosure date will appear here after more snapshots are available. | |||||